Journal Article

Selenium Nanoparticles Pre-Treatment Reverse Behavioral, Oxidative Damage, Neuronal Loss and Neurochemical Alterations in Pentylenetetrazole-Induced Epileptic Seizures in Mice

Yuan, Xiaona, Alkandiri, Ali, Habotta, Ola A, Abdel Moneim, Ahmed E, Fu, Zhenshuai, Ji, Pengfei, Al-Ghamdy, Ali O, Kassab, Rami B, Guo, Lubo

2020

Overview

Epilepsy is a chronic neurological condition characterized by behavioral, molecular, and neurochemical alterations. Current antiepileptic drugs are associated with various adverse impacts. The main goal of the current study is to investigate the possible anticonvulsant effect of selenium nanoparticles (SeNPs) against pentylenetetrazole (PTZ)-mediated epileptic seizures in mice hippocampus. Sodium valproate (VPA) was used as a standard anti-epileptic drug. Mice were assigned into five groups (n=15): control, SeNPs (5 mg/kg, orally), PTZ (60 mg/kg, intraperitoneally), SeNPs+PTZ and VPA (200 mg/kg)+PTZ. All groups were treated for 10 days. PTZ injection triggered a state of oxidative stress in the hippocampal tissue as represented by the elevated lipoperoxidation, heat shock protein 70 level, and nitric oxide formation while decreased glutathione level and antioxidant enzymes activity. Additionally, the blotting analysis showed downregulation of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) in the epileptic mice. A state of neuroinflammation was recorded following the developed seizures represented by the increased pro-inflammatory cytokines. Moreover, neuronal apoptosis was recorded following the development of epileptic convulsions. At the neurochemical level, acetylcholinesterase activity and monoamines content were decreased in the epileptic mice, accompanied by high glutamate and low GABA levels in the hippocampal tissue. However, SeNP supplementation was found to delay the onset and decreased the duration of tonic, myoclonic, and generalized seizures following PTZ injection. Moreover, SeNPs were found to provide neuroprotection through preventing the development of oxidative challenge via the upregulation of Nrf2 and HO-1, inhibiting the inflammatory response and apoptotic cascade. Additionally, SeNPs reversed the changes in the activity and levels of neuromodulators following the development of epileptic seizures. The obtained results suggest that SeNPs could be used as a promising anticonvulsant drug due to its potent antioxidant, anti-inflammatory, and neuromodulatory activities.

• Publisher: Taylor & Francis Ltd,Dove,Dove Medical Press
• Subject: Alzheimer's disease / Amino Acids / Animals / Anti-Inflammatory Agents - pharmacology / Anti-Inflammatory Agents - therapeutic use / Anticonvulsants / Anticonvulsants - adverse effects / Anticonvulsants - pharmacology / Anticonvulsants - therapeutic use / Antioxidants / Apoptosis / Apoptosis - drug effects / Cholinergic Agents - metabolism / Convulsions & seizures / Drug dosages / Enzymes / Epilepsy / gaba and glutamate / Hippocampus - drug effects / Hippocampus - pathology / Investigations / Laboratory animals / Male / Mice / monoamines / Nanoparticles / Nanoparticles - administration & dosage / Nanoparticles - chemistry / Nanotechnology / neuroinflammation and apoptosis / Neurons - drug effects / Neurons - pathology / Neurotransmitter Agents - metabolism / Oral administration / Original Research / Oxidation-Reduction / Oxidative stress / Oxidative Stress - drug effects / Particle size / Pentylenetetrazole / Seizures - chemically induced / Seizures - drug therapy / Seizures - prevention & control / Selenium / Selenium - administration & dosage / Selenium - pharmacology / Selenium - therapeutic use / selenium nanoparticles / Zoology